Increased IL-33 in synovial fluid and paired serum is associated with disease activity and autoantibodies in rheumatoid arthritis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Tang, Sumei ^a   Huang, Heqing ^a,b   Hu, Fanlei ^a   Zhou, Wei ^c   Guo, Jianping ^a   Jiang, Huirong ^d   Mu, Rong ^a   Li, Zhanguo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GLUCOSE 6 PHOSPHATE ISOMERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 33; RHEUMATOID FACTOR; BIOLOGICAL MARKER; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JOINT SWELLING; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; ADOLESCENT; BLOOD; CHILD; IMMUNOLOGY; METABOLISM; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT; ARTHRITIS, RHEUMATOID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL FLUID; YOUNG ADULT;

EID: 84885349430     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/985301     Document Type: Article

References (20)

1. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T. K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D. M., Bazan J. F., Kastelein R. A., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005 23 5 479 490 2-s2.0-27744446058 10.1016/j.immuni.2005.09.015 (Pubitemid 41587888)
2. Xu D., Jiang H.-R., Kewin P., Li Y., Mu R., Fraser A. R., Pitman N., Kurowska-Stolarska M., McKenzie A. N. J., McInnes I. B., Liew F. Y., IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 31 10913 10918 2-s2.0-49449111630 10.1073/pnas.0801898105
3. Palmer G., Talabot-Ayer D., Lamacchia C., Toy D., Seemayer C. A., Viatte S., Finckh A., Smith D. E., Gabay C., Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis and Rheumatism 2009 60 3 738 749 2-s2.0-61649117392 10.1002/art.24305
4. Leung B. P., Xu D., Culshaw S., McInnes I. B., Liew F. Y., A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. Journal of Immunology 2004 173 1 145 150 2-s2.0-2942702125 (Pubitemid 38797335)
5. Carriere V., Roussel L., Ortega N., Lacorre D.-A., Americh L., Aguilar L., Bouche G., Girard J.-P., IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007 104 1 282 287 2-s2.0-33846101552 10.1073/pnas.0606854104 (Pubitemid 46068023)
6. Matsuyama Y., Okazaki H., Tamemoto H., Kimura H., Kamata Y., Nagatani K., Nagashima T., Hayakawa M., Iwamoto M., Yoshio T., Tominaga S.-I., Minota S., Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. Journal of Rheumatology 2010 37 1 18 25 2-s2.0-73649098450 10.3899/jrheum.090492
7. Mu R., Huang H.-Q., Li Y.-H., Li C., Ye H., Li Z.-G., Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis. Journal of Rheumatology 2010 37 10 2006 2013 2-s2.0-77957883154 10.3899/jrheum.100184
8. Xiangyang Z., Lutian Y., Lin Z., Liping X., Hui S., Jing L., Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine 2012 58 1 6 9 2-s2.0-84857447895 10.1016/j.cyto.2011.12.010
9. Talabot-Ayer D., McKee T., Gindre P., Bas S., Baeten D. L., Gabay C., Palmer G., Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Joint Bone Spine 2012 79 1 32 37 2-s2.0-84855653658 10.1016/j.jbspin.2011.02.011
10. Hochberg M. C., Chang R. W., Dwosh I., Lindsey S., Pincus T., Wolfe F., The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis and Rheumatism 1992 35 5 498 502 2-s2.0-0026629688
11. Altman R., Asch E., Bloch D., Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis and Rheumatism 1986 29 8 1039 1049 2-s2.0-0022465236
12. Prevoo M. L. L., Van 'T Hof M. A., Kuper H. H., Van Leeuwen M. A., Van De Putte L. B. A., Van Riel P. L. C. M., Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 1995 38 1 44 48 2-s2.0-0028815803 10.1002/art.1780380107
13. Vittecoq O., Pouplin S., Krzanowska K., Jouen-Beades F., Ménard J. F., Gayet A., Daragon A., Tron F., Le Loët X., Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 2003 42 8 939 946 2-s2.0-0141839077 10.1093/rheumatology/keg257 (Pubitemid 37220959)
14. Vander Cruyssen B., Hoffman I. E. A., Peene I., Union A., Mielants H., Meheus L., De Keyser F., Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope. Annals of the Rheumatic Diseases 2007 66 3 364 369 2-s2.0-34147219949 10.1136/ard.2006.053470 (Pubitemid 46579639)
15. Hoffman I. E. A., Peene I., Pottel H., Union A., Hulstaert F., Meheus L., Lebeer K., De Clercq L., Schatteman L., Poriau S., Mielants H., Veys E. M., De Keyser F., Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis. Clinical Chemistry 2005 51 1 261 263 2-s2.0-19944366229 10.1373/clinchem.2004.034728 (Pubitemid 40024055)
16. Hayakawa H., Hayakawa M., Kume A., Tominaga S.-I., Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. Journal of Biological Chemistry 2007 282 36 26369 26380 2-s2.0-34548825396 10.1074/jbc.M704916200 (Pubitemid 47443815)
17. Yanagisawa K., Tsukamoto T., Takagi T., Tominaga S., Murine ST2 gene is a member of the primary response gene family induced by growth factors. FEBS Letters 1992 302 1 51 53 2-s2.0-0026583599 10.1016/0014-5793(92)80282-L
18. Kumar S., Tzimas M. N., Griswold D. E., Young P. R., Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochemical and Biophysical Research Communications 1997 235 3 474 478 2-s2.0-0031587953 10.1006/bbrc.1997.6810 (Pubitemid 27326503)
19. Weinberg E. O., Shimpo M., De Keulenaer G. W., MacGillivray C., Tominaga S.-I., Solomon S. D., Rouleau J.-L., Lee R. T., Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002 106 23 2961 2966 2-s2.0-0037016036 10.1161/01.CIR.0000038705.69871.D9 (Pubitemid 35424749)
20. Oshikawa K., Kuroiwa K., Tago K., Iwahana H., Yanagisawa K., Ohno S., Tominaga S.-I., Sugiyama Y., Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. American Journal of Respiratory and Critical Care Medicine 2001 164 2 277 281 2-s2.0-0035880170 (Pubitemid 34001295)